Geneva, March 20 -- International Clinical Trials Registry received information related to the study (NCT07450716) titled 'Assessing the Efficacy and Safety of Photobiomodulation for the Treatment of Pruritus' on Feb. 26.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Single (Participant).
Primary Sponsor: Massachusetts General Hospital
Condition:
Pruritus
Intervention:
Device: Light-emitting diode (LED) Photobiomodulation (PBM) device
Recruitment Status: Not recruiting
Phase: Early Phase 1
Date of First Enrollment: March 2026
Target Sample Size: 20
Countries of Recruitment:
United States
To know more, visit https://clinicaltr...